EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulation of Nrf2/ GPX4 Signaling Pathway by Hyperbaric Oxygen Protects Against Depressive Behavior and Cognitive Impairment in a Spinal Cord Injury Rat Model

Chenlu Li iD, Zhongyue Wu, Fuxiang Chen, Chaoxian Dai, Xinyi Yang, Shumin Ye, Meng Shi, Peng Chen, Xueyan Liu iD, Fang Liu iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Chenlu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hyperbaric Oxygen, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou,…. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, NF-E2-Related Factor 2, Cognitive Dysfunction, Depression. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Joint Fund Project, Fujian province, Fujian Provincial Finance Project, Fujian Provincial Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Neuroinflammation, microglial activation, and oxidative stress contribute to neuropsychiatric deficits following spinal cord injury ( SCI ). Hyperbaric oxygen ( HBO ) therapy has demonstrated anti‐inflammatory, antioxidant, and neuroprotective properties. This study aimed to investigate the therapeutic effects and underlying mechanisms of HBO on depressive‐like behavior, cognitive impairment, and hippocampal pathology in a rat model of SCI .

Methods

We employed a battery of behavioral assessments, unbiased stereological analysis, immunofluorescence staining, and biochemical assays to evaluate neuroinflammation, oxidative stress, mitochondrial damage, and iron accumulation in the hippocampus. Untargeted proteomic analysis was conducted to identify potential molecular targets of HBO . Western blotting was used to assess the activation of the Nrf2/ GPX4 signaling pathway. ML385 , a selective Nrf2 inhibitor, was intrathecally administered 30 min prior to daily HBO treatment to validate pathway involvement.

Results

HBO treatment significantly alleviated depressive‐like behavior and cognitive deficits in SCI rats. It also suppressed M1 ‐type microglial activation and reduced hippocampal neuroinflammation. Additionally, HBO mitigated neuronal ferroptosis induced by SCI through activation of the Nrf2/ GPX4 signaling pathway. The protective effects of HBO were abolished by coadministration of ML385 , confirming the critical role of Nrf2 signaling in mediating its anti‐ferroptosis effects.

Conclusion

These findings highlight ferroptosis as a key pathological mechanism in SCI ‐induced hippocampal damage and suggest that HBO therapy alleviates depressive‐like behavior and cognitive impairment by targeting the Nrf2/ GPX4 pathway. This study provides new insights into the therapeutic potential of HBO in managing SCI ‐related neuropsychiatric dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperbaric OxygenationNF-E2-Related Factor 2Cognitive DysfunctionDepressionSpinal Cord InjuriesPhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsRatsSignal TransductionRats, Sprague-DawleyMaleHippocampusDisease Models, Animal

Stichwörter der Autor:innen

GPX4cognitive impairmentdepressive behaviorferroptosishyperbaric oxygenproteomicsspinal cord injury

Substanzen

NF-E2-Related Factor 2Nfe2l2 protein, ratPhospholipid Hydroperoxide Glutathione Peroxidaseglutathione peroxidase 4, rat

Autor:innen und Institutionen

  • Department of Hyperbaric Oxygen, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Radiology, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, China.
  • Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Sports Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fujian, China.

ORCID-Profile: Chenlu Li, Xueyan Liu, Fang Liu

Förderung

  • Science and Technology Innovation Joint Fund Project, Fujian province
  • Fujian Provincial Finance Project
  • Fujian Provincial Health Technology Project

Zitieren

APA

Li, C., Wu, Z., Chen, F., Dai, C., Yang, X., Ye, S., Shi, M., Chen, P., Liu, X., & Liu, F. (2025). Regulation of Nrf2/ GPX4 Signaling Pathway by Hyperbaric Oxygen Protects Against Depressive Behavior and Cognitive Impairment in a Spinal Cord Injury Rat Model. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70421

Vancouver

Li C, Wu Z, Chen F, Dai C, Yang X, Ye S, et al. Regulation of Nrf2/ GPX4 Signaling Pathway by Hyperbaric Oxygen Protects Against Depressive Behavior and Cognitive Impairment in a Spinal Cord Injury Rat Model. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70421

BibTeX
@article{Li2025,
  author = {Li, Chenlu and Wu, Zhongyue and Chen, Fuxiang and Dai, Chaoxian and Yang, Xinyi and Ye, Shumin and Shi, Meng and Chen, Peng and Liu, Xueyan and Liu, Fang},
  title = {Regulation of Nrf2/ GPX4 Signaling Pathway by Hyperbaric Oxygen Protects Against Depressive Behavior and Cognitive Impairment in a Spinal Cord Injury Rat Model},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70421}
}
Kostenlos starten →